LUNG CANCER, NON-SQUAMOUS, NON-SMALL CELL

Clinical trials for LUNG CANCER, NON-SQUAMOUS, NON-SMALL CELL explained in plain language.

Never miss a new study

Get alerted when new LUNG CANCER, NON-SQUAMOUS, NON-SMALL CELL trials appear

Sign up with your email to follow new studies for LUNG CANCER, NON-SQUAMOUS, NON-SMALL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New pill aims to outperform chemo for tough lung cancer

Disease control Recruiting now

This study is testing if a new oral medicine called zongertinib works better than the current standard IV treatment for adults with advanced lung cancer that has a specific genetic change (HER2 mutation). Participants, who have not yet received treatment for their advanced cancer…

Matched conditions: LUNG CANCER, NON-SQUAMOUS, NON-SMALL CELL

Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Feb 25, 2026 15:06 UTC

LUNG CANCER, NON-SQUAMOUS, NON-SMALL CELL

Get alerted when new LUNG CANCER, NON-SQUAMOUS, NON-SMALL CELL trials appear

New pill aims to outperform chemo for tough lung cancer